Harvard Bioscience, Inc. Forecast, price target & analysts
Harvard Bioscience, Inc. Target price 2026 - Analyst rating & recommendation
Harvard Bioscience, Inc. Classifications & Recommendation
Harvard Bioscience, Inc. Price Target
| Target Price | $7.65 |
| Price | $7.96 |
| Deviation |
3.89%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Harvard Bioscience, Inc. 2027 .
The average Harvard Bioscience, Inc. target price is $7.65.
This is
3.89%
register free of charge
$7.88
1.07%
register free of charge
$7.58
4.84%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Harvard Bioscience, Inc. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harvard Bioscience, Inc. stock has an average upside potential 2027 of
3.89%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 86.55 | 91.60 |
| 8.06% | 5.83% | |
| EBITDA Margin | 4.15% | 9.63% |
| 3,354.02% | 132.17% | |
| Net Margin | -65.51% | -1.93% |
| 396.96% | 97.05% |
4 Analysts have issued a sales forecast Harvard Bioscience, Inc. 2026 . The average Harvard Bioscience, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Harvard Bioscience, Inc. EBITDA forecast 2026. The average Harvard Bioscience, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Harvard Bioscience, Inc. Analysts have issued a net profit forecast 2026. The average Harvard Bioscience, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -12.77 | -0.39 |
| 348.07% | 96.95% | |
| P/E | negative | |
| EV/Sales | 0.73 |
4 Analysts have issued a Harvard Bioscience, Inc. forecast for earnings per share. The average Harvard Bioscience, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Harvard Bioscience, Inc....
Current Harvard Bioscience, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Benchmark |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Mar 13 2026 |
| Benchmark |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Benchmark:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Mar 16 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Mar 13 2026 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
